纵横研报
Ticker Detail

605177.SHG

¥16.35-0.85% 东亚药业 Biotechnology
00Reports China 医疗健康
Zhejiang East Asia Pharmaceutical Co. Ltd.
医疗健康 · 生物科技

Zhejiang East Asia Pharmaceutical Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules in China and internationally. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products. The company's products are used in cardiovascular, anti-aging, dementia, digestive system, diabetic neuropathy, anti-pathogenic microorganisms, infection, and central nervous system fields. It exports its products. The company was founded in 1998 and is headquartered in Taizhou, China.

MARKET 市值 1.88B CNY 52W ¥15.45 – ¥24.7 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 38.6% ROE -6.1% 营业利润率 -5.7% 净利润率 -10.9%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制